国际标准期刊号: 2168-9652

生物化学与生理学:开放获取

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • CAS 来源索引 (CASSI)
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • Genamics 期刊搜索
  • 学术钥匙
  • 期刊目录
  • 乌尔里希的期刊目录
  • 电子期刊图书馆
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 学者指导
  • SWB 在线目录
  • 虚拟生物学图书馆 (vifabio)
  • 普布隆斯
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

PTGS2 Effectively Suppress Dendritic Cell Immunity

M. Salahuddin, MdSaidur Rahman, A K Paul, Md. Selim Ahmed, and Mohammad Alam Miah

Prostaglandin-endoperoxide synthase (PTGS), also known as cyclooxygenase (COX), is a key enzyme in prostaglandin biosynthesis,regulates dioxygenase and peroxidase activity. The major metabolites of PTGS2 are PGE2, PGF2, PGD2, PGI2, and TXA2. All of these are steroid and act as immunosuppressive agentsbut differ in their regulation of expression and tissue distribution. It is a well-known fact that PTGS2 prompt and aggrandize the cancer condition by proliferation, differentiation, and migration of carcinogenic cells in different organs in animals including human, therefore considered as a novel target for the prevention of cancer. Several researchers have discoverednumerous pharmacological inhibitors of PTGS2 to prevent the cancer,however prevention and treatment of cancer by inhibiting PTGS2 from dendritic cell has not been properly studied. Therefore, indirect/direct molecular silencing of PTGS2 by siRNA/shRNA or PTGS2 knockout from DC to prevent cancer means PTGS2 mediated DC vaccine may be an attractive approach to prevent cancer in near future.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。